cbdMD, Inc. (YCBD)
cbdMD, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
cbdMD, Inc. (YCBD) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $8.5M. Revenue declined 1.5% year-over-year and free cash flow was negative at -$1.6M. This page tracks YCBD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 42 employees · IPO Nov 17, 2017
Valuation
Valuation & price
$0.77as of May 17, 2026· -66.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.18
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$8.5M
Market cap
-1.5%
Revenue growth (YoY)
62.4%
Gross margin
-$1.6M
Free cash flow (USD)
$776M
Net debt
-6.7%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 14, 2026 (EPS $-0.08)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is cbdMD, Inc.'s market cap?
cbdMD, Inc. (YCBD) has a market capitalization of $8.5M.
What is YCBD's P/E ratio?
A meaningful P/E ratio is not available for YCBD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is YCBD's price-to-book (P/B) ratio?
YCBD trades at 1.18 times book value per share.
When did cbdMD, Inc. last report earnings?
YCBD last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying YCBD stock?
SEC Form 4 filings show no open-market insider buys at cbdMD, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Drug Manufacturers - Specialty & Generic
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.